We are up early, as usual, and looking forward to a busy day. Before we rouse the short people and feed the dog, though, we thought we might share a few of the more interesting items that have come our way...
Abbott Labs Doesn't See Any M&A Deals This Year (Yahoo/Reuters)
Genzyme & Isis Strike $325M Deal Over Cholesterol Drug (Bloomberg News)
Biogen Presentation Impresses Investors (PharmaTimes)
J&J's Cordis Wins Appeal On Stent Patent (Yahoo/Reuters)
Pfizer To Buy APIs From India's Hikal (The Business Standard)